Europe Circulating Biomarkers, Exosomes & Liquid Biopsy Conference 2019 (Rotterdam, Netherlands – October 30, 2019 November 1, 2019) –

Biomarkers, Exosomes & Liquid Biopsy Europe 2019”

conference has been added to’s

Exosomes and Liquid Biopsy Europe 2019 to be held in Rotterdam, The

This annual conference now in its Fifth Year brings together academics
and industry participants from around the world focused on research,
biomarker analyses and therapeutics development leveraging the cargo
from Exosomes and Extracellular Vesicles (EVs).

An important component of this conference is to focus upon the
development of liquid biopsies utilizing circulating cell-free DNA
(cfDNA), circulating tumor cells (CTCs) and other biomarkers found in

Presentations, Panel Discussions and Round-Table Workshops from key
opinion leaders in the field form the basis of this conference and
companies/vendors in the space participate to showcase their most
up-to-date product and service offerings.

Rotterdam is an excellent host city for this conference with its
excellent infrastructure, fast connections across Europe and easy access
from around the world via Amsterdam-Schiphol.

Who Should Attend:

  • Senior Academic researchers involved in research and technology
  • Senior Industry researchers involved in R&D
  • Business Development professionals in companies involved in technology
    evaluation, licensing and partnering/business development activities
  • Young investigators/researchers embarking on their research careers –
    excellent opportunity to learn the latest science and excellent
    networking opportunities to build collaborations
  • Students and post-doctoral fellows – opportunity to present their
    research to a worldwide audience via posters and build their
    professional networks, collaborations and career development


  • Circulating Cell-Free DNA (cfDNA) for Liquid Biopsy Development

    • Companies Showcase
    • Technologies for Mutation Detection and Analysis
  • Circulating Tumour Cells (CTCs) for Liquid Biopsy Development

    • Companies Showcase
    • Emerging Technology Trends
  • Exosomes and Extracellular Vesicles (EV) Biomarker Potential

    • Proteins, DNA and Lipids
    • RNA Cargo
  • Exosomes and Extracellular Vesicles (EV) Research Trends
  • Exosomes and Extracellular Vesicles (EV) Studies in Various Diseases

    • Cancer
    • Cardiovascular Disease
    • CNS Disease
  • Isolation and Characterization of Exosomes and EV Classes
  • Modification and Engineering of Exosomes and EVs
  • Therapeutics Opportunities: Targeting using Exosomes/EVs


Catherine Alix-Panabières


University Medical Centre of Montpellier

Director of the Laboratory of Rare Human Circulating Tumor Cells,
University Medical Centre of Montpellier

Leon Terstappen

University of Twente

Chair Medical cell biophysics, MIRA Research Institute for Biomedical
Technology and Technical Medicine, University of Twente

Paul Robbins


University of Minnesota Medical School

Professor, Department of Biochemistry, Molecular Biology, and
Biophysics, and the Institute on the Biology of Aging and Metabolism,
University of Minnesota Medical School

Klaus Pantel


University Of Hamburg

Director, University Of Hamburg

Patrizia Paterlini-Brechot


University Paris Descartes

Professor of Oncology/Molecular Biology, University Paris Descartes

Takahiro Ochiya


National Cancer Center Research Institute Japan

Chief, National Cancer Center Research Institute Japan

Graham Pockley

CEO, Director and Professor

multimmune GmbH

Director and Professor, John van Geest Cancer Research Centre,
Nottingham Trent University, CEO, multimmune GmbH

Dominique PV de Kleijn


University Medical Center Utrecht

Professor, University Medical Center Utrecht

For more information about this conference visit

Laura Wood, Senior Press Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Biomarkers

Thank you for donating to

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation